Simply Solventless Concentrates Past Earnings Performance
Past criteria checks 4/6
Simply Solventless Concentrates has been growing earnings at an average annual rate of 706.2%, while the Pharmaceuticals industry saw earnings growing at 51% annually. Revenues have been growing at an average rate of 53.2% per year. Simply Solventless Concentrates's return on equity is 15.9%, and it has net margins of 11.7%.
Key information
706.2%
Earnings growth rate
579.7%
EPS growth rate
| Pharmaceuticals Industry Growth | 23.1% |
| Revenue growth rate | 53.2% |
| Return on equity | 15.9% |
| Net Margin | 11.7% |
| Last Earnings Update | 31 Mar 2024 |
Recent past performance updates
Recent updates
Revenue & Expenses Breakdown
How Simply Solventless Concentrates makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
| Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
|---|---|---|---|---|
| 31 Mar 24 | 7 | 1 | 2 | 0 |
| 31 Dec 23 | 6 | 1 | 1 | 0 |
| 30 Sep 23 | 7 | 0 | 1 | 0 |
| 30 Jun 23 | 6 | 1 | 1 | 0 |
| 31 Mar 23 | 4 | 0 | 1 | 0 |
| 31 Dec 22 | 3 | -2 | 1 | 0 |
| 31 Dec 21 | 1 | -2 | 2 | 0 |
Quality Earnings: HASH has high quality earnings.
Growing Profit Margin: HASH's current net profit margins (11.7%) are higher than last year (2.2%).
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: HASH has become profitable over the past 5 years.
Accelerating Growth: Insufficient data to compare HASH's past year earnings growth to its 5-year average.
Earnings vs Industry: HASH earnings growth over the past year (706.2%) exceeded the Pharmaceuticals industry 39.8%.
Return on Equity
High ROE: HASH's Return on Equity (15.9%) is considered low.